RESEARCHARTICLE
Translational control of nociception via
4E-binding protein 1
Arkady Khoutorsky1,2†, Robert P Bonin3†, Robert E Sorge4,5†,
Christos G Gkogkas1,6, Sophie Anne Pawlowski5,7, Seyed Mehdi Jafarnejad1,2,
Mark H Pitcher8, Tommy Alain1,2, Jimena Perez-Sanchez3, EricW Salter3,
Loren Martin4,5, Alfredo Ribeiro-da-Silva5,7, Yves De Koninck3,5,7,9,
Fernando Cervero5,10, Jeffrey S Mogil4,5*, Nahum Sonenberg1,2*
1Department of Biochemistry, McGill University, Montre´al, Canada; 2Rosalind and
Morris Goodman Cancer Research Centre, McGill University, Montre´al, Canada;
3Unite´ de neurosciences cellulaires et mole´culaire, Institut universitaire en sante´
mentale de Que´bec, Que´bec, Canada; 4Department of Psychology, McGill
University, Montre´al, Canada; 5Alan Edwards Centre for Research on Pain, McGill
University, Montre´al, Canada; 6Centre for Integrative Physiology and The Patrick
Wild Centre, University of Edinburgh, Edinburgh, United Kingdom; 7Department of
Pharmacology and Therapeutics, McGill University, Montreal, Canada; 8National
Center for Complementary and Alternative Medicine, National Institutes of Health,
Porter Neuroscience Research Center, Maryland, United States; 9Department of
Psychiatry and Neuroscience, Universite´ Laval, Que´bec, Canada; 10Anesthesia
Research Unit, McGill University, Montreal, Canada
*Forcorrespondence:jeffrey. Abstract Activationofthemechanistic/mammaliantargetofrapamycin(mTOR)kinaseinmodels
mogil@mcgill.ca(JSM);nahum. ofacuteandchronicpainisstronglyimplicatedinmediatingenhancedtranslationand
sonenberg@mcgill.ca(NS) hyperalgesia.However,themolecularmechanismsbywhichmTORregulatesnociceptionremain
†Theseauthorscontributed unclear.Hereweshowthatdeletionoftheeukaryoticinitiationfactor4E-bindingprotein1(4E-
BP1),amajormTORdownstreameffector,whichrepresseseIF4Eactivityandcap-dependent
equallytothiswork
translation,leadstomechanical,butnotthermalpainhypersensitivity.Micelacking4E-BP1exhibit
Competinginterest:See
enhancedspinalcordexpressionofneuroligin1,acell-adhesionpostsynapticproteinregulating
page15
excitatorysynapsefunction,andshowincreasedexcitatorysynapticinputintospinalneurons,and
Funding:Seepage15 aloweredthresholdforinductionofsynapticpotentiation.PharmacologicalinhibitionofeIF4Eor
geneticreductionofneuroligin1levelsnormalizestheincreasedexcitatorysynapticactivityand
Received:1October2015
reversesmechanicalhypersensitivity.Thus,translationalcontrolby4E-BP1downstreamofmTOR
Accepted:01November2015
effectstheexpressionofneuroligin1andexcitatorysynaptictransmissioninthespinalcord,and
Published:18December2015
therebycontributestoenhancedmechanicalnociception.
Reviewingeditor: DavidD DOI:10.7554/eLife.12002.001
Ginty,HowardHughesMedical
Institute,HarvardMedical
School,UnitedStates
Thisisanopen-accessarticle, Introduction
freeofallcopyright,andmaybe
De novo gene expression induced by noxious stimuli markedly contributes to the development of
freelyreproduced,distributed,
pain hypersensitivity (i.e., allodynia and hyperalgesia). Regulation of gene expression at the level of
transmitted,modified,built
translationenablesthecelltorapidlychangeitsproteomebymodulatingtherateofmRNAtransla-
upon,orotherwiseusedby
tion without altering mRNA levels (Sonenberg and Hinnebusch, 2009). Upregulation of mRNA
anyoneforanylawfulpurpose.
Theworkismadeavailableunder translationviaactivationofthemechanical/mammaliantargetofrapamycin(mTOR)bynoxiousstim-
theCreativeCommonsCC0 uli has been proposed to sensitize primary nociceptors and spinal circuits (Bogen et al., 2012;
publicdomaindedication. Ferrarietal.,2013;Jimenez-Diazetal.,2008;Melemedjianetal.,2010;ObaraandHunt,2014;
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 1of18
Researcharticle Biochemistry Neuroscience
eLife digest Despitetheunpleasantfeelingitcauses,painisnecessaryforsurvivalasithelps
individualstoavoidobjects,environmentsandsituationsthatcausedamagetotheirbody.However,
millionsofpeopleexperiencelong-lasting“chronic”pain,orarehypersensitivetopain.Thereare
fewtreatmentsavailablefortheseconditions,butthesetreatmentsdonotworkwellforthemajority
ofpatients,andcanhaveserioussideeffects.Todevelopnewtreatments,researchersmustfirst
betterunderstandhowchronicpaindevelops.
Pain is transmitted to the brain in the form of electrical signals “fired” along nerve fibers.
Differentnervestransmitinformationaboutdifferenttypesofpain:forexample,paincausedbya
sharpobjectpressedagainsttheskinactivatesadifferentsetofneuronstothoseactivatedwhen
touchingsomethingdangerouslyhot.StudiesinmicehavesuggestedthataproteincalledmTOR
thatisfoundinsideneuronsisimportantforthemtofirepainsignals.However,itisnotclearexactly
howmTORcontributestopainsignaling,althoughitisknowntoaffecttheactivitiesofseveralother
proteinsinneurons.
One protein that mTOR affects the activity of is called 4E-BP1. Now, Khoutorsky, Bonin, Sorge
etal.showthatmicethatlack4E-BP1behaveinwaysthatsuggesttheyarehypersensitivetopoking
orpinchingsensations.However,themicedidnotshowhypersensitivitywhentheytouchedahot
surface.Furtherinvestigationrevealedthattheneuronsinthespinalcordofmicethatlack4E-BP1
produceabnormallyhighamountsofamoleculecalledneuroligin1,whichmakestheneuronsmore
likelytofireandthussignalpain.
Khoutorsky, Bonin, Sorge et al. found that treating mice that lack 4E-BP1 with a compound that
reducesneuroligin1productioncausestheirneuronstofiremorenormally.Thisalsoreducesthe
animals’apparentsignsofhypersensitivitytopressureontheirskin.Itwillbeimportantinfuture
studiestoidentifyadditionaltargetsof4E-BP1inthespinalcordthatcouldcontributetoincreased
mechanicalsensation,andalsotostudytheroleof4E-BP1inperipheralnerves.
DOI:10.7554/eLife.12002.002
Price and Geranton, 2009). mTOR is an evolutionarily conserved serine/threonine kinase that con-
trols cell homeostasis through key molecular processes including translation, lipid biogenesis,
autophagy, and cytoskeleton organization (Shimobayashi and Hall, 2014). mTOR is the catalytic
subunit of two structurally and functionally distinct multiprotein complexes, mTORC1 and mTORC2
(Lipton and Sahin, 2014). mTORC1 is defined by the protein raptor and is sensitive to rapamycin,
whilemTORC2isdefinedbytheproteinrictorandisrapamycininsensitive.mTORC1isakeyregula-
tor of translation, whereas mTORC2 controls the actin cytoskeleton (Jacinto et al., 2004;
Sarbassov et al., 2004). The mTORC1 pathway is activated in primary nociceptors and superficial
dorsal horn neurons in rodent models of inflammatory pain (Jiang et al., 2013; Liang et al., 2013;
NorstedGregoryetal.,2010;Xuetal.,2011),bonecancer-inducedpain(Shihetal.,2012),neu-
ropathicpain(Zhangetal.,2013),andinresponsetorepeatedmorphineadministration(Xuetal.,
2015; Xu et al., 2014). The functional role of mTORC1 activation has been studied using the
mTORC1 specific inhibitor, rapamycin, and its derivatives (rapalogues). Systemic or intrathecal (i.t.)
administration of rapalogues does not affect acute responses to mechanical and thermal stimuli
(Geranton et al., 2009; Xu et al., 2014), but it reduces nocifensive behaviors, and normalizes
mechanicalhypersensitivityinrodentmodelsofinflammatorypain(Asanteetal.,2009;Jiangetal.,
2013;PriceandGeranton,2009;Priceetal.,2007),bonecancer-inducedpain(Shihetal.,2012),
and neuropathic pain (Asante et al., 2010; Cui et al., 2014; Zhang et al., 2013). Taken together,
thesefindingsindicatethatnoxiousstimuli-inducedactivationofmTORC1playsanimportantrolein
the development of pain hypersensitivity. However, the cellular and molecular mechanisms mediat-
ingtheeffectofmTORC1onnociceptionarenotknown.
AllnucleartranscribedeukaryoticmRNAsharbor,attheir5’end,thestructurem7GpppN(where
Nisanynucleotide)termed‘cap’,whichfacilitates ribosomerecruitmenttothemRNA.Recruitment
ofthe ribosome to the mRNA is primarily regulated at the initiation step. A critical step of this pro-
cess is the assembly of the eukaryotic initiation factor 4F (eIF4F) complex, which consists of eIF4E,
the cap binding protein subunit, eIF4G, a large scaffold protein, and eIF4A, an RNA helicase that
unwinds the mRNA 5’ UTR (untranslated region) secondary structure. Because eIF4E generally
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 2of18
Researcharticle Biochemistry Neuroscience
exhibits the lowest expression level of all eukaryotic initiation factors, the cap-recognition step is
rate-limiting for translation and a major target for regulation (Sonenberg and Hinnebusch, 2009).
mTORC1 is a key regulator of translation initiation via phosphorylation of its downstream targets,
eIF4E-binding proteins (4E-BPs) and p70S6 kinases (S6Ks). In their hypo-phosphorylated form, 4E-
BPscompetewitheIF4GforbindingtoeIF4EtorepresseIF4Fcomplexassembly,andtherebytrans-
lation initiation. Following phosphorylation by mTORC1, 4E-BPs dissociate from eIF4E, allowing for
eIF4F complex formation and activation of translation (Gingras et al., 1996). Three 4E-BP isoforms
(1, 2, and 3) have similar functions, differing in their tissue distribution. 4E-BP3 expression is limited
to few tissues, and is excluded from the nervous system. In the forebrain, 4E-BP2 is the major iso-
form, and 4E-BP2 knockout mice exhibit enhanced excitation (Gkogkas et al., 2013; Ran et al.,
2013),alterationsinsynapticplasticity,memory(Bankoetal.,2007;Bankoetal.,2005),andsocial
behavior (Gkogkas et al., 2013). In the suprachiasmatic nucleus, 4E-BP1 controls circadian clock
functions via regulation of vasoactive intestinal polypeptide (Vip) mRNA translation (Cao et al.,
2013). In the pain pathway, 4E-BP1 is expressed in neurons in the dorsal horn of the spinal cord,
and in peripheral nerves (Jimenez-Diaz et al., 2008; Melemedjian et al., 2011), whereas in
thedorsalrootganglion(DRG)itwasdetectedonlyinsatelliteglialcells(Xuetal.,2010).
Decreasing S6Ks activity by either pharmacological inhibitors or S6K1/2 null mutation unexpect-
edly led to mechanical allodynia via activation of ERK, a well-known pain sensitizing molecule
(Melemedjianetal.,2013).ActivationofERKiscausedbydisinhibitionoftheS6K1/IRS-1/ERKnega-
tive feedback loop (Carracedo et al., 2008). Here, we investigated the role of the other major
mTORC1 downstream effectors, 4E-BPs, in nociception using Eif4ebp1 and 2 knockout (Eif4epb-/-)
mice.Removalof4E-BP1and2relieveseIF4Esuppressionandprovidesanopportunitytostudycel-
lularandmolecularmechanismsunderlyingtheimpactofmTORC1,via4E-BPs,onnociception.Pre-
viousworkshowedthatintraplantaradministrationoftwowell-knownsensitizersofnociceptors,IL-6
and NGF, upregulates eIF4F complex formation and cap-dependent translation in primary afferent
neurons (Melemedjian et al., 2010). Peripheral inhibition of eIF4F with a specific inhibitor, 4EGI-1,
completelyblockedIL-6-andNGF-inducedmechanicalallodynia,supportingtheideathatenhanced
eIF4Fcomplexformationandcap-dependenttranslationcontributetosensitizationofprimaryaffer-
ents. However, the roles of eIF4F and 4E-BPs in the regulation of spinal circuits are unknown. Here
weshowthatEif4ebp1-/-,butnotEif4ebp2-/-miceexhibitmechanical(butnotthermal)hypersensitiv-
ity,which canberescuedbyintrathecaladministration of4EGI-1.Mechanical hypersensitivity isalso
elicited by downregulation of 4E-BP1 in the spinal cord dorsal horn. In Eif4ebp1-/- mice, the excit-
atory synaptic input into spinal neurons is enhanced and the threshold for potentiation of electri-
cally-evoked field post-synaptic potentials (fPSPs) in the superficial dorsal horn is lowered. The
enhancementofexcitatory synaptictransmission ismediated viaincreasedsynthesis ofneuroligin1,
which promotestheexcitatory synapsefunction. Reduction ofneuroligin1levelsinEif4ebp1-/- mice
normalizesexcitatory synaptictransmission,andpartially reversesmechanical allodynia.Collectively,
ourdatademonstratethatde-repressionofeIF4E,viaremovalof4E-BP1,contributestomechanical
allodynia through a neuroligin 1-mediated increase in the excitatory synaptic drive to the spinal cir-
cuit, and provides a new paradigm to explain the mechanisms by which mTORC1 controls
nociception.
Results
4E-BP1 ablation induces mechanical hypersensitivity
Tostudytheroleof4E-BPsandeIF4Finnociception,weassessedmechanicalandthermalsensation
in Eif4ebp1-/-, Eif4ebp2-/-, and Eif4ebp1-/-/2-/- mice and wild-type controls. Eif4ebp1-/- mice exhib-
itedamarkedincreaseinmechanical sensationinvonFreyand tailcliptests(45%decreaseinwith-
drawal threshold and 52% reduction in latency to attack tail clip, respectively, Figure 1A), whereas
their thermal sensitivity was unaffected in both the radiant heat paw-withdrawal and hot-plate tests
(Figure1B).Additionally,inthechemical/inflammatoryformalintest(20ml,0.5%formalin,intraplan-
tar) Eif4ebp1-/- mice showed higher levels of nocifensive behavior (Figure 1C) and increased c-Fos
expression in the dorsal horn of the lumbar spinal cord (Figure 1D). In contrast, Eif4ebp2-/- mice
showed no mechanical (von Frey and tail clip tests, Figure 1—figure supplement 1A) or thermal
pain phenotype (radiant heat paw-withdrawal and hot-plate tests, Figure 1—figure supplement
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 3of18
Researcharticle Biochemistry Neuroscience
Figure1.Eif4ebp1-/-miceexhibitmechanicalhypersensitivityandincreasedformalinresponse.MechanicalpainsensitivityisincreasedinEif4ebp1-/-
miceasevidentbydecreasedvonFreythresholds(A,n=8/genotype)andshortenedlatenciestoattacktailclip(A,n=8/genotype),whereasthermal
sensitivityisnotaltered(B,n=8/genotype).(C)Eif4ebp1-/-miceshowmorenocifensive(licking/shaking)behavioroftheinjectedhindpawthantheir
wild-type(WT)littermatesintheformalintest(0.5%,20ml,n=8/genotype).Changesinpawweight,indicativeofformalin-inducedinflammation,were
notdifferentinEif4ebp1-/-mice(notshown).(D)Intraplantarinjectionofformalin(0.5%,20ml)inducedanenhancedupregulationofc-Fos(2hpost
injection)insuperficiallayers(I-II)ofthelumbarspinalcordofEif4ebp1-/-ascomparedtoWTmice(n=3mice/group,10sections/mouse).(E)Western
blotanalysisoflysatespreparedfromthedorsalhornofthelumbarspinalcordandL3/L4DRGssevendayspostintraparenchymaldorsalhorninjection
oflentivirusesexpressingshRNAagainstEif4ebp1ascomparedtonon-targeting(scrambled)shRNA(n=3/condition).MiceinjectedwithshRNAagainst
Eif4ebp1exhibitareductioninvonFreythreshold7dayspostinjection(F,n=9/condition),whereasthermalsensitivityisnotaltered(G,n=9/condition).
Dataarepresentedasmean±SEM.*p<0.05,**p<0.01,***p<0.001,ns–notsignificantbyStudent’st-testort-testfollowingrepeatedmeasures
ANOVA.Scalebar:100mm.Seealsofiguresupplement1and2.
DOI:10.7554/eLife.12002.003
ThefollowingfiguresupplementsareavailableforFigure1:
Figuresupplement1.Eif4ebp1/2DKOmice,butnotEif4ebp2-/-,miceexhibitmechanicalhypersensitivityandenhancedformalinresponding.
DOI:10.7554/eLife.12002.004
Figure1.continuedonnextpage
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 4of18
Researcharticle Biochemistry Neuroscience
Figure1.Continued
Figuresupplement2.NogrossalterationsinthedorsalhornoftheEif4ebp1-/-mice.
DOI:10.7554/eLife.12002.005
Figuresupplement3.Distributionoflentivirus-driveneGFPexpression.
DOI:10.7554/eLife.12002.006
1B), and no alterations in formalin test behavior (Figure 1—figure supplement 1C). Mice lacking
both 4E-BP1 and 4E-BP2 (Eif4ebp1-/-/2-/-) showed mechanical hypersensitivity and increased pain
behavior informalin test (Figure 1—figure supplement 1D–F), a phenotype identical to Eif4ebp1-/-
mice. We did not detect any reorganization of the dorsal horn of Eif4ebp1-/- mice as assessed by
neuronal marker NeuN (Figure 1—figure supplement 2A), projection of peptidergic (expressing
substance P (SP) and calcitonin gene-related peptide (CGRP), Figure 1—figure supplement 2B,C)
or non-peptidergic (expressing isolectin B4 (IB4), Figure 1—figure supplement 2D) C fibers, distri-
bution of glial marker glial fibrillary acidic protein (GFAP, Figure 1—figure supplement 2E), and
5HT3Areceptor(HTR3A,Figure1—figuresupplement2F).Toexcludethepossibilitythatthephe-
notypesobservedinEif4ebp1-/- animals weretheresultoflong-termdevelopmental compensations
andtotesttheroleof4E-BP1selectivelyinthespinalcord,weknockeddownEif4ebp1inthedorsal
horn of adult wild-type mice using an intraparenchymal injection of lentivirus expressing shRNA
against Eif4ebp1. The virus-driven eGFP expression was restricted to the dorsal horn and showed
mostlyneuronallocalization(Figure1—figuresupplement3).SevendaysafterinjectionofEif4ebp1
shRNAintothedorsalhornofthelumbarspinalcord,miceshowedreducedlevelsof4E-BP1protein
in the lumbar spinal cord (53 ± 9% reduction, Figure 1E), but not in DRGs, and exhibited mechani-
cal,butnotthermalhypersensitivity(Figure1F–G).Tostudythedistributionof4E-BP1and4E-BP2,
we performed western blot analysis of proteins prepared from DRG and superficial spinal cord,
which showed the presence of4E-BP1, but muchless of the4E-BP2 isoform (Figure 1—figure sup-
plement 2G). Taken together, our data demonstrate that 4E-BP1 is the predominant functional iso-
form in the pain pathway and its downregulation in the spinal cord elicits mechanical
hypersensitivity.
4E-BP1suppresseseIF4FcomplexformationbycompetingwitheIF4GforbindingtoeIF4E.Thus,
removal of 4E-BP1 leads to increased levels of the eIF4F complex (Gkogkas et al., 2013;
Pause et al., 1994; Tahmasebi et al., 2014). Therefore, we measured eIF4F complex levels in
Eif4ebp1-/- mice using a cap-binding assay (see experimental procedures). As expected, in the lum-
bar spinal cord lysates, the amount of eIF4G associated with the cap-bound eIF4E was higher in
Eif4ebp1-/-miceascomparedtowild-typemice(Figure2A).Next,weusedaninhibitoroftheeIF4F
complex,4EGI-1,whichbindstoeIF4EandinhibitsitsinteractionwitheIF4G.Dailyi.t.administration
oflow doses of 4EGI-1 (10 mg) over three days normalized the enhanced binding of eIF4G to eIF4E
inEif4ebp1-/-mice(Figure2A),andrescuedthemechanicalhypersensitivityandenhancedformalin-
inducedpainbehaviorinthesemice(Figure2B–C).Thesedataindicatethatthemechanicalsensitiv-
ityandincreasedresponsesintheformalintestinEif4ebp1-/-miceareaconsequenceofaugmented
eIF4Fcomplexformation.
Next, we investigated the molecular and cellular mechanisms underlying the mechanical hyper-
sensitivityofEif4ebp1-/-mice.Wefocusedonspinalmechanismsbywhich4E-BP1controlsmechani-
cal sensitivity. mTOR and 4E-BPs are strongly implicated in the regulation of synaptic transmission
and synaptic plasticity in pyramidal hippocampal neurons (Gkogkas et al., 2013; Ran et al., 2013;
RichterandKlann,2009;Santinietal.,2013;Westonetal.,2012).Thus,wemeasuredspontane-
ous miniature excitatory and inhibitory postsynaptic inputs into lamina II spinal neurons in spinal
cord slices prepared from Eif4ebp1-/- and wild-type mice. The amplitude of miniature excitatory
postsynaptic currents (mEPSCs) was increased in spinal neurons in Eif4ebp1-/- as compared to wild-
type slices, whereas there was no statistically significant change in mEPSC frequency (Figure 3A).
The amplitude and frequency of inhibitory postsynaptic currents (mIPSC) were increased in
Eif4ebp1-/- mice (Figure 3B). In the spinal cord, fast inhibitory synaptic transmission is mediated via
GABA and glycine receptors. Interestingly, while glycinergic mIPSC amplitude and frequency were
enhanced,noalterationsweremeasuredinGABA -mediatedsynaptictransmission(Figure3C).The
A
increaseinthemEPSCamplitudeinlaminaIIspinalneuronsofEif4ebp1-/-wasreversedbyi.t.admin-
istration of 4EGI-1 (10 mg, daily for 3 days, Figure 3D), however, 4EGI-1 had no effect on the
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 5of18
Researcharticle Biochemistry Neuroscience
Figure2.IncreasedlevelsofeIF4FcomplexinEif4ebp1-/-micecausemechanicalhypersensitivityandincreasedformalinresponse.(A)Left,
Immunoblotanalysisofcapcolumnpull-downproteinspreparedfromthespinalcordofEif4ebp1-/-andwild-typemice(WT)treatedwith4EGI-1(10
mg,i.t.onceadayfor3days)orvehicle.Right,quantificationofeIF4G1incapcolumnpull-downmaterial(n=4/genotype/drug).(B)Chronic4EGI-1
treatmentrescuesmechanicalhypersensitivityofEif4ebp1-/-mice.vonFreythresholdwasmeasuredpriorto(baseline)andafter4EGI-1chronic
treatment(10mg,i.t.,onceadayfor3days,n=8/genotype/drug).(C)Chronic4EGI-1treatmentnormalizestheenhancednocifensive(licking/shaking)
behaviorofEif4ebp1-/-miceduringtheearly(0–10minpost-formalin,0.5%)andlatephases(10–60minpost-formalin)oftheformalintest(n=8/
genotype/drug).Dataarepresentedasmean±SEM.*p<0.05,**p<0.01byStudent’st-testfollowingtwo-way(genotypexdrug)ANOVA(inA,C)or
followingtwo-between(genotype,drug),one-within(repeatedmeasures)ANOVA(inB).
DOI:10.7554/eLife.12002.007
increased amplitude and frequency of mIPSC (Figure 3E). The reasons for these differences will be
addressedintheDiscussion.
Additionally, we measured potentiation of fPSPs in Eif4ebp1-/-and wild-type lumbar spinal cords
bystimulatingdorsalroots(2Hz)andrecordingextracellularfPSPsinthesuperficiallayerofthespi-
nal cord. The threshold for induction of potentiation was lowered in Eif4ebp1-/- as compared to
wild-type mice, since potentiation was elicited with 40s of stimulation in Eif4ebp1-/- spinal cords,
whereasinwild-typespinalcords60 sofstimulationwererequiredtopotentiateEPSPs(Figure3F).
Theextentofpotentiationachievedwith60 sofstimulationwas37.5%higherinEif4ebp1-/-ascom-
pared to wild-type spinal cords. Together, the results demonstrate that basal synaptic transmission
isenhanced,andthethresholdforinductionofsynapticpotentiationisloweredinEif4ebp1-/-mice.
Based on the effects of translational de-repression on synaptic physiology, as a consequence of
4E-BP1depletion,wereasonedthattranslationofspecificmRNAs,whichregulatesynaptictransmis-
sion, is affected. Consistent with previous reports, e.g.Tahmasebi et al., 2014, wefound nodiffer-
ences in rates of general translation between wild-type and Eif4ebp1-/- mice, using the puromycin
incorporation assay (Figure 4A), supporting the idea that alterations in translation of a small subset
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 6of18
Researcharticle Biochemistry Neuroscience
Figure3.ExcitatoryandinhibitorysynaptictransmissionsareincreasedinthespinalcordofEif4ebp1-/-mice.Representativetraces(top)ofmEPSCs(A)
andmIPSCs(B)fromlaminaIIneuronsinacutelumbarspinalcordslicesfromEif4ebp1-/-andwild-typemice(WT).Bargraphs(bottom)showmEPSC
(A)andmIPSC(B)amplitude,frequencyandsynaptictotalchargetransfer(A:n=8WT;n=7Eif4ebp1-/-;B:n=9WT;n=7Eif4ebp1-/-).(C)Toisolate
GABA orglycinergicmIPSCs,strychnine(STRY,glycinereceptorantagonist,1mM)orbicuculline(BIC,GABA receptorantagonist,10mM)wereused,
A A
respectively.Left:representativetracesofmIPSCinthepresenceofstrychnineorbicucullinefromEif4ebp1-/-andWTslices.Right:bargraphsshowing
mIPSCamplitudeandfrequencyinthepresenceofstrychnine(n=7WT;n=8Eif4ebp1-/-)orbicuculline(n=9WT;n=8Eif4ebp1-/-).Eif4ebp1-/-micewere
treatedwith4EGI-1(10mg,dailyfor3days,i.t.)orvehicle,andthemEPSCs(D)andmIPSCs(E)wererecordedfromlaminaIIneurons(n=7vehicle;n=11
4EGI-1).(F)Synapticpotentiationwaselicitedbystimulationofthedorsalroot(2Hz)for20,40and60sandrecordingfEPSPs125mmfromthedorsal
surfaceofthespinalcord.SynapticpotentiationisinducedinEif4ebp1-/-,butnotWTspinalcordpreparation,by40sstimulation.Left:representative
tracesoffEPSPs,evokedbystimulationfortheindicatedlengthoftime.Right:bargraphshowingthesummaryofsynapticpotentiationduringthelast
5minpriortostimulation(n=7WT;n=8Eif4ebp1-/-).Dataarepresentedasmean±SEM.*p<0.05,**p<0.01,***p<0.001byStudent’st-test(A,B,D,E),
orbyStudent’st-testfollowingtwo-wayANOVA(genotypexdruginC;genotypexdurationinF).
DOI:10.7554/eLife.12002.008
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 7of18
Researcharticle Biochemistry Neuroscience
Figure4.Enhancedexpressionofneuroligin1contributestomechanicalhypersensitivityofEif4ebp1-/-mice.(A)Generaltranslationisnotalteredin
Eif4ebp1-/-miceasassessedbypuromycinincorporation(n=3/genotype).(B)Proteinexpressionofneuroligin(NLGN)1,2and3isincreasedin
synaptosomespreparedfromthedorsalhornofthelumbarspinalcordofEif4ebp1-/-mice(n=5/genotype),whereastheirmRNAlevelsarenotchanged
(C).(D)Wild-type(WT)andEif4ebp1-/-miceweretreatedwith4EGI-1(10mg,dailyfor3days,i.t.)orvehicle,andtheproteinlevelsofneuroligin1were
measuredinlysatespreparedfromthedorsalhornofthelumbarspinalcordusingwesternblotanalysis(n=5/condition).(E)Nlgn1-/-miceexhibit
elevatedvonFreythresholds,whereasNlgn1+/-miceshownoalterationinmechanicalsensitivity(n=10WTandNlgn1-/-;n=15Nlgn1+/-).(F)Deletionof
onealleleofNlgn1inEif4ebp1knockoutmice(Eif4ebp1-/-/Nlgn1+/-)normalizesneuroligin1proteinlevelsinthedorsalhornofthelumbarspinalcord
ofEif4ebp1-/-mice(left)andpartiallyattenuatesmechanicalallodyniaofEif4ebp1-/-mice(right,n=10wild-type,n=7Eif4ebp1-/-,n=14Eif4ebp1-/-/
Nlgn1+/-).Dataarepresentedasmean±SEM.*p<0.05,**p<0.01,ns–notsignificant,byStudent’st-test(A–C),Bonferronipost-hoctestfollowingtwo-
between(genotype,condition)one-within(repeatedmeasures)ANOVA(E),orBonferronipost-hoctestfollowingone-wayANOVA(F).
DOI:10.7554/eLife.12002.009
of mRNAs engender nociceptive phenotypes in Eif4ebp1-/- mice. We previsouly investigated the
mechanismsunderlyingtheenhancedexcitatoryandinhibitorysynaptictransmissioninhippocampal
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 8of18
Researcharticle Biochemistry Neuroscience
neuronsofEif4ebp2-/-mice(Gkogkasetal.,2013).4E-BP2isthemajor4E-BPisoforminthehippo-
campus(Bankoetal.,2005).Membersofthefamilyofpost-synapticadhesionproteins,neuroligins,
were upregulated in the hippocampus of 4E-BP2 depleted mice, leading to changes in synaptic
transmission. Specifically, translation of neuroligin (Nlgn) 1, 2 and 3 mRNAs was increased in the
brain of Eif4ebp2-/- mice. Neuroligin 1 controls excitatory synapse formation, maturation, and func-
tion,whereasneuroligin2regulatesinhibitorysynaptictransmission(Kruegeretal.,2012).Neuroli-
gin 3 controls both excitatory and inhibitory synapses. An additional study has revealed a
translational upregulation of a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor
(AMPA) receptor subunits, Glua1 and Glua2 in response to 4E-BP2 ablation (Ran et al., 2013). Pro-
tein levels of neuroligins (1–3) were increased in synaptosomes prepared from Eif4ebp1-/- spinal
cords (Figure 4B), whereas their mRNA levels were unaltered (Figure 4C), suggesting that transla-
tion of neuroligin 1–3 mRNAs is increased in Eif4ebp1-/- mice. No differences in Glua1 and Glua2
proteinexpressionwerefoundinEif4ebp1-/-spinalcords(Figure4B).
Inlightoftheseresultswehypothesizedthattheincreasedexcitatorysynapticinputintothespi-
nalneuronsandmechanicalhypersensitivityinEif4ebp1-/-micearetheresultofincreasedneuroligin
1 expression, which is known to strongly promote excitatory synaptic transmission. The enhanced
expression of neuroligin 1 in Eif4ebp1-/- spinal cord was normalized by 4EGI-1 treatment (10 mg,
daily for 3 days, i.t. Figure 4D), consistent with our finding that 4EGI-1 normalizes the increased
mEPSCamplitudeinEif4ebp1-/-spinalneurons(Figure3D).Tostudytheroleofneuroligin1innoci-
ception,weexaminedmice with anullmutation ofneuroligin 1.Nlgn1-/- miceshowed elevated von
Frey thresholds (Figure 4F), indicating reduced mechanical sensation, whereas heterozygous mice
(Nlgn1+/-) exhibited no change in their mechanical thresholds. Next, we normalized the enhanced
expressionofneuroligin1inEif4ebp1-/- micebyremovingonealleleofNlgn1.Tothisend,wegen-
erated Eif4ebp1-/-/ Nlgn1+/- double knockout mice and compared their mechanical sensitivity to
Eif4ebp1-/- littermates. Deletion of one allele of Nlgn1 in Eif4ebp1-/- mice normalized the increased
neuroligin1expression(Figure4G)andreversedmechanicalsensitivity(Figure4G).Takentogether,
ourdatademonstratethatelevatedlevelsofneuroligin1contributetothemechanicalhypersensitiv-
ityofEif4ebp1-/-mice.
Finally,weexploredwhethertheincreaseinexcitatorysynaptictransmissioninEif4ebp1-/-miceis
mediated via enhanced expression of neuroligin 1. Strikingly, deletion of one allele of Nlgn1 in
Eif4ebp1-/- mice (Eif4ebp1-/-/Nlgn1+/-) rescued the enhanced excitatory synaptic transmission
(mEPSCamplitudeandtotalchargetransfer)inspinalneurons(Figure5A),buthadnoeffectonthe
inhibitorysynapses(Figure5B).Nodifferenceswerefoundininputresistanceandmembranecapac-
itance of spinal neuron between the four genotypes examined (Figure 5—figure supplement 1).
Thus, our data demonstrate that the enhanced expression of neuroligin 1 in mice lacking 4E-BP1
strengthensexcitatoryspinalsynapses,andtherebycontributestomechanicalhypersensitivity.
Discussion
mTORC1 stimulates translation by relieving the 4E-BP-mediated block on eIF4F complex formation
and cap-dependent translation. IL-6 and NGF-mediated enhancement of eIF4F complex formation
play an important role in mediating mechanical nociceptive plasticity in primary afferent neurons
(Melemedjian et al., 2010). However, the roles of eIF4F and 4E-BPs in regulation of spinal circuits
remain unknown. Here, we show that de-repression of translation by removal of 4E-BP1 leads to
enhanced eIF4F complex formation in the spinal cord, and to mechanical hypersensitivity and
increased response to noxious chemical/inflammatory stimuli. This effect was observed in both
Eif4ebp1-/- miceandinmicewithselectivedownregulationof4E-BP1inthespinalcorddorsalhorn.
Normalization of eIF4F complex levels in Eif4ebp1-/- mice by intrathecal administration of 4EGI-1
reversed the exaggerated mechanical sensation, thus demonstrating that the enhanced eIF4F com-
plexistheunderlyingcauseformechanicalhypersensitivityinEif4ebp1-/-mice.
eIF4F controls translation of a specific subset of mRNAs. Consistent with this and with previous
reports (Gkogkas et al., 2013; Tahmasebi et al., 2014), we found that general translation is not
altered in Eif4ebp1-/- mice (Figure 4A), indicating that upregulated translation of certain mRNAs
contributes to the nociceptive phenotypes of these mice. Previous studies have documented
that mRNAs in the family of neuroligin proteins are being translationally activated by eIF4F in the
nervoussystem,suchasinmiceoverexpressingeIF4Eorlacking4E-BP2(Gkogkasetal.,2013).We
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 9of18
Researcharticle Biochemistry Neuroscience
Figure5.Reductionofneuroligin1levelsinEif4ebp1-/-micenormalizestheenhancedexcitatorysynaptictransmission.mEPSCs(A)andmIPSCs(B)
wererecordedfromlaminaIIspinalneuronsofwild-type(WT),Eif4ebp1-/-,Eif4ebp1-/-/Nlgn1+/-andNlgn1+/-mice.Top:representativetracesof
recordingsfromthefourgenotypes.Bottom:bargraphshowingmEPSC(A)andmIPSC(B)amplitude,frequencyandsynaptictotalchargetransfer
(n=11WT;n=9Eif4ebp1-/-;n=10Eif4ebp1-/-/Nlgn1+/-;n=7Nlgn1+/-).TheincreaseinmEPSCamplitudeandtotalchargeinEif4ebp1-/-miceisrescued
followingdeletionofoneNlgn1allele,whereasmIPSCsarenotaffected.Dataarepresentedasmean±SEM.*p<0.05byBonferronipost-hoctest
followingone-wayANOVA.Seealsofiguresupplement1.
DOI:10.7554/eLife.12002.010
ThefollowingfiguresupplementsareavailableforFigure5:
Figuresupplement1.InputresistanceandmembranecapacitancearenotalteredinlaminaIIspinalneuronsfromEif4ebp1-/-,Eif4ebp1-/-/Nlgn1+/-and
Nlgn1+/-mice.
DOI:10.7554/eLife.12002.011
thereforereasonedthattheenhancedmechanicalnociceptioninEif4ebp1-/-micecouldbemediated
via enhanced translation of Nlgn mRNAs. Indeed, we found that the expression of neuroligins was
increased in the spinal cord of Eif4ebp1-/- mice without concomitant changes in mRNA levels, indi-
cating enhanced translation. The role of neuroligins in the spinal cord is not well studied. A recent
study showed that knock-down of neuroligin 2, which promotes inhibitory synaptic transmission, in
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 10of18
Researcharticle Biochemistry Neuroscience
thespinal cordofnaı¨verats increasesmechanical sensitivity(Doliqueet al.,2013). The roleofneu-
roligin 1, which promotes excitatory synaptic transmission, in pain processing has not been investi-
gated. Consistent with the higher levels of neuroligin 1, 2 and 3 in mice lacking 4E-BP1, we found
that excitatory and inhibitory spinal synaptic transmission are increased in these animals. Chronic
painisassociatedwithanincreaseintheexcitatorysynapticdrivetodorsalhornneurons(Sandkuh-
ler,2009).Therefore,inthecurrentstudywefocusedonneuroligin1anditsroleinpromotingexcit-
atorysynaptictransmissioninEif4ebp1-/-mice.
Interestingly, the enhancement of mEPSC amplitude and neuroligin 1 spinal expression in
Eif4ebp1-/- mice was rescued by intrathecal 4EGI-1. In agreement with these results, we also found
thatmechanicalsensationisreducedinNlgn1-/- mice,indicatingthatneuroligin1hasapronocicep-
tive function. Strikingly, normalization of neuroligin 1 levels rescued the increased mEPSC ampli-
tudesinEif4ebp1-/-mice,andpartiallyreversedthemechanicalhypersensitivityinthesemice.These
data strongly indicate that augmented spinal expression of neuroligin 1 in Eif4ebp1-/- mice contrib-
utestomechanicalhypersensitivityvianeuroligin1-inducedupregulationofexcitatorysynaptictrans-
missioninthespinalcord.Thefindingthatnormalizationofneuroligin1levelsonlypartiallyreverses
mechanical hypersensitivity in Eif4ebp1-/- mice indicates that additional mechanisms, peripheral or
central,downstreamof4E-BP1/eIF4econtributetothepainphenotype.
WeobservedthattheincreasedinhibitioninEif4ebp1-/-miceissolelymediatedviaenhancedgly-
cinergic, but not GABAergic synaptic transmission (Figure 3C). Similarly to GABA , glycine recep-
A
tors mediate fast synaptic inhibition in the spinal cord, where they regulate nociceptive and tactile
sensoryprocessing.Littleisknownabouthowsynapticstrengthofglycinergicsynapsesisregulated
invivo.Surprisingly,wefoundthattheinhibitorysynaptictransmission wasnotaffectedbyintrathe-
caladministrationof4EGI-1,possiblybecauseofreducedsensitivityto4EGI-1orbecauseinhibitory
synaptictransmissionisregulatedby4EGI-1insensitiveprocessesdownstreamof4E-BP1.Thediffer-
ential regulation of glycinergic synaptic transmission by mTOR/4E-BP1 pathway in the spinal cord is
intriguing, and further studies will be necessary to better understand the precise molecular mecha-
nism of this regulation. However, the increased inhibition in Eif4ebp1-/- mice was not reversed by
normalization of neuroligin 1 expression (Figure 5B), and is thus unlikely to play major role in the
reducednociceptivethresholdsofEif4ebp1-/-mice,whichwerereversedbynormalizationofneuroli-
gin1expression(Figure4E,G).
The threshold for enhancement of electrically-evoked field potentials is lowered in Eif4ebp1-/-
mice. This finding is consistent with studies in the hippocampus showing that 4E-BP2 ablation
engenders the conversion of early-phase long-term potentiation (LTP) into late-phase LTP in the
Schaffer collateral pathway (Banko et al., 2005). Lowered threshold for LTP induction is thought to
beamechanismcontributingtoincreasedresponsivenessofspinalcircuitsunderconditionsofpath-
ological pain (Ji et al., 2003; Sandkuhler, 2009). An mTORC1-mediated increase in eIF4F complex
formation, which leads to the enhancement of synaptic transmission and lowering of the threshold
fortheinductionofsynapticpotentiation,islikelytocontributetoabnormalpainprocessinginmod-
els of chronic pain. Though our study demonstrates an important role of enhanced expression of
neuroligin 1 in the nociceptive phenotype of Eif4ebp1-/- mice, it is conceivable that translational
upregulation of other mRNAs contributes to the regulation of nociception downstream of mTORC1
andribosome-profilingstudiesarerequiredtoidentifythesetranscripts.
OurdatademonstratethatthemTOR/4E-BP/eIF4Epathwaycontrolsmechanical,butnotthermal
sensitivity.Arecentstudyshowedthatsomatostatin-positive cells,whichareenrichedinlaminaIIof
the dorsal horn where they comprise 53% of all glutamatergic excitatory neurons, are required for
sensationofmechanicalbutnotthermalpain(Duanetal.,2014).Interestingly,wefoundthatlamina
IIneuronsreceivestrongerexcitatoryinputinEif4ebp1-/- mice(Figure3),raisingtheintriguingpos-
sibilitythattheeffectof4E-BP1depletiononmechanical,butnotthermalsensation,couldbemedi-
atedviaincreasedexcitatorydrivetosomatostatin-positiveneurons.Conditionaldeletionof4E-BP1
insomatostatinpositivecellswillberequiredtoaddressthisidea.
mTORC1 controls protein synthesis as well as lipid and ribosome biogenesis, autophagy and
mitochondriafunction(Costa-MattioliandMonteggia,2013;ShimobayashiandHall,2014).Stud-
ies with rapalogues have shown that mTORC1 is strongly implicated in the development of hyper-
sensitivity states in a variety of pain models (Obara and Hunt, 2014; Price and Geranton, 2009).
However,whethertheeffectsofmTORC1onnociceptionaremediatedviatranslationcontrolmech-
anisms or via protein synthesis-independent functions of mTORC1 have remained largely unknown.
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 11of18
Researcharticle Biochemistry Neuroscience
Our study clearly shows that translational regulators (4E-BP1 and eIF4F), acting downstream of
mTOR,controlnociceptionviatheireffectonmechanicalsensationandsynapticresponses.
In summary, our results shed important light on the mechanisms by which activation of the
mTOR/4E-BP/eIF4E pathway enhances mechanical pain sensation. We show that 4E-BP1 is a major
functional isoform in the pain pathway, where it represses translation of neuroligins in the spinal
cord.Removalof4E-BP1increasesneuroligin1expression,whichinturnpromotesexcitatorysynap-
tictransmissioninthespinalcordandleadstomechanicalhypersensitivity.
Material and methods
Mice
Eif4ebp1,Eif4ebp2andEif4ebp1/2nullmutantmicewerebackcrossedformorethan10generations
into a C57BL/6J background (Le Bacquer et al., 2007). Nlgn1 knockout mice were kindly provided
by Craig M. Powell (The University of Texas Southwestern Medical Center, Dallas). Wild-type mice
were littermates of the corresponding knockout mice. All behavioral experiments were performed
on 8–12-week-old mice of both sexes by male experimenters blinded to genotype and drug. Food
andwaterwereprovided adlibitum,andmice werekeptona12:12hrlight/darkcycle(lightsonat
08:00hr). All procedures complied with the Canadian Council on Animal Care guidelines and Inter-
nationalAssociationfortheStudyofPain,andwereapprovedbyMcGillUniversity’sDowntownAni-
malCareCommittee.
Behavioral assays
vonFreyTesting:MicewereplacedindividuallyintransparentPlexiglascubicles(5(cid:2)8.5(cid:2)6cm)set
on a perforated steel floor and habituated for 1hr prior to testing. Nylon monofilaments (Stoelting
#2-#9)werefirmlyappliedtotheplantarsurfaceofeachhindpawfor0.5s.Theup-downmethodof
Dixon (Chaplan et al., 1994) was used to estimate the 50% withdrawal threshold (average of two
measurementsforbothhindpawsseparatedbyatleast30min).
Tail Clip test: A small alligator clip (700g force) was applied at 1 cm from the base of the tail.
The latency to attack/bite the clip was measured with a stopwatch to the nearest 0.1 sec. Upon
attack,theclipwasremovedandtheanimalswerereturnedtotheircages.
Radiant Heat Paw-Withdrawal: Mice were placed in cubicles (described above) on a glass floor
and a focused beam of high-intensity light was aimed at the plantar surface of the hind paw. The
intensity of the light was set to 15% or 20% of maximum (IITC Model 390) with a cut-off value of
40s. The latency to withdraw the hindpaw was measured to the nearest 0.1 s. Measurements con-
sistedoftestingbothhindpawstwiceontwoseparateoccasionsseparatedbyatleast30min.
Hot-plate test: Mice were placed into a clear Plexiglas cylinder atop a metal surface (Columbus
Instruments) maintained at 50˚C. The latency to lick or shake either hind paw was measured with a
stopwatchtothenearest0.1sec.
Formalin test: Mice were placed into Plexiglas cylinders on a glass floor and habituated for at
least 30min. Following habituation, all mice were given intraplantar injections of formalin (20 ml,
0.5%) into the left hind paw and placed back into the cylinders. Cameras, placed under the glass
floor,recorded the lickingbehavior over 60min. Video files weresampled at1-minintervals forthe
presenceorabsenceoflickingbehaviorinthefirst10secofeachinterval.Dataareexpressedasthe
percent of positive (licking) samples. The early phase of the formalin test was defined as 0–10min.
andthelatephaseas10–60min.post-injection.
Electrophysiology
Electrophysiological recordings of miniature excitatory and inhibitory post-synaptic currents
(mEPSCs and mIPSCS) and dorsal root-evoked field post-synaptic potentials (fPSPs) were made
usinglumbarspinalcordtissue.Adult(3(cid:0)6monthsold)malemicewereanesthetizedwithurethane
(2g/kg) and perfused with ice-cold sucrose-substituted artificial cerebral spinal fluid (sucrose artifi-
cial cerebro-spinal fluid [aCSF]; contains in mM: 252 sucrose, 2.5 KCl, 1.5 CaCl , 6 MgCl , 10 d-glu-
2 2
cose,bubbled with 95%:5% oxygen:CO ). The lumbarspinal column wasremovedand immersedin
2
ice-cold sucrose aCSF after which the spinal cord was quickly removed via laminectomy. For patch-
clamp experiments, the dorsal and ventral roots were removed from the spinal cord and 300 mm-
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 12of18
Researcharticle Biochemistry Neuroscience
thickparasagittalsliceswerecutfromthelumbarportioninice-coldsucroseaCSF.Aftercutting,the
spinal cord slices were kept in oxygenated (95% O , 5% CO ) aCSF (in mM: 126 NaCl, 2.5 KCl, 2
2 2
MgCl ,2CaCl ,1.25NaH PO ,26NaHCO ,10d-glucose)atroomtemperatureuntilrecording.For
2 2 2 4 3
LTP experiments, the ventral roots and connective tissue were removed from the spinal cord after
laminectomy, and the tissue explant was placed in room temperature aCSF for 1hr before
experimentation.
In most patch-clamp experiments, slices were continuously perfused (8 ml/min) with oxygenated
aCSF supplemented with tetrodotoxin (1 mM). Lamina II cells were visually identified and patched
with borosilicate pipettes containing (in mM): 110 CsMeSO , 11 Cs-EGTA, 10 CsCl, 20 HEPES, 2
3
MgCl , 1 CaCl , 4 Mg-ATP, 0.4 Tris-GTP, 0.1% (w/v) Lucifer Yellow; pH was adjusted to 7.2 with
2 2
CsOH. Synaptic events were low-pass filtered at 2 kHz and recorded at 10 kHz using a Multiclamp
700B amplifier (Molecular Devices, Sunnyvale, CA), Digidata 1322A digitizer (Molecular Devices),
and pClamp 10 software (Molecular Devices). DL-2-amino-5-phosphonovaleric acid (AP5; 40 mM)
was added to the aCSF to block NMDA receptors. mEPSCs and mIPSCs were recorded at holding
potentialsof-70mVand0mV,respectively.ForexperimentsdesignedtoisolateGABA orglyciner-
A
gicmIPSCs,strychnine(1mM)orbicuculline(10mM)wereaddedtotheaCSF,respectively,andvisu-
ally identified lamina II cells were patched with pipettes containing (in mM): 120 CsCl, 5 KCl, 11
EGTA, 1 CaCl , 4 Na-ATP, 0.4 Na-GTP, 10 HEPES and 0.1% Lucifer Yellow (wt/vol), pH 7.2. Stable
2
3min recordings of mEPSCs and mIPSCs were selected for analysis in Clampfit 10 (Molecular
Devices).
Electrically-evoked field potentials in the superficial dorsal horn were recorded as previously
described (Bonin and De Koninck, 2014). fPSPs were recorded via a borosilicate glass electrode
insertedintothedorsalsideofthespinalcordexplantinthedorsalrootentryzone.Electrodeswere
inserted superficially to a depth of no more than 125 mm from the dorsal surface of the spinal cord
measuredwithanMPC-200manipulator(SutterInstrumentCompany,Novato,CA,USA).Electrodes
hadatipresistanceof3(cid:0)4MWwhenfilledwithaCSF.fPSPswereevokedbyelectricalstimulationof
the dorsal root using a suction electrode that is pulled from borosilicate glass and filled with aCSF,
and placed near the cut end of the dorsal root. Field potentials were amplified with a Multiclamp
700Bamplifier(MolecularDevices,Sunnyvale,CA,USA),digitizedwithaDigidata1322A(Molecular
Devices), and recorded using pClamp 10 software (Molecular Devices). Data were filtered during
acquisition with a low pass filter set at 1.6 kHz and sampled at 10 kHz. Test stimuli were presented
every 60s to evoke fPSPs and LTP was evoked by stimulation at 2Hz for variable lengths of time.
The stimulus intensity was sufficient to activate C-fibers, as indicated by the appearance of a third
distinct fiber volley after the stimulus artifact (Bonin and De Koninck, 2014), while a slightly
(10(cid:0)20%) higher intensity was used to induce synaptic potentiation. Data were analyzed using
ClampFit10software(MolecularDevices).TheareaoffPSPsrelativetobaselinewasmeasuredfrom
0(cid:0)800msaftertheonsetofthefPSP.
Drugs
4EGI-1waspurchasedfromCalbiochem(SanDiego,CA)anddissolvedfirstinDMSO(stocksolution)
and then in 30% polyethylene glycol. All drugs and chemicals for electrophysiology experiments
werepurchasedfromSigma-Aldrich(Oakville,ON,Canada).
Western blotting
Tissue extracts for western blotting were prepared in ice-cold homogenization buffer containing (in
mM): 20 Tris-HCl, pH 7.4; 150 NaCl; 1 EDTA; 1% Triton, 5 NaF; 1.5 Na VO and protease inhibitor
3 4,
cocktail (complete, EDTA-free, Roche Applied Science). Synaptosomes were prepared using Syn-
PER Synaptic Protein Extraction Reagent (Thermo Scientific CAT#8779. Following centrifugation at
12,000(cid:2)gfor10min,thesupernatantproteinconcentrationwasmeasuredandsamplescontaining
equal protein amounts were boiled for 5min in Laemmli sample buffer and separated by SDS-
PAGE. Following electrophoresis, proteins were transferred to 0.2 mm nitrocellulose membranes.
Membranes were blocked in 5% dry milk powder in Tris-buffered saline containing 0.1% Tween-20
(TBS-T) for 1hr prior to overnight incubation with the primary antibody. The membranes were then
washed, incubated for 1h with HRP-conjugated secondary antibody, washed again, treated with
Enhanced Chemiluminescence reagent (Perkin Elmer), and exposed to an autoradiography film
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 13of18
Researcharticle Biochemistry Neuroscience
(Denville Scientific Inc.). All signals were obtained in the linear range for each antibody, quantified
using ImageJ (NIH), and in some experiments normalized to b-actin. The western blot experiments
were performed in triplicate. The antibodies and the dilutions for the western blots used are as fol-
lows:4E-BP1(1:1000, Cat#9644,CellSignaling Technology),4E-BP2 (1:1000,Cat#2845,CellSignal-
ing Technology), eIF4E (1:1000, Cat#610269, BD Transduction Laboratories), eIF4G1 (1:1000,
Cat#ab2609Abcam),neuroligin1–3(1:1000,SynapticSystems),GluA1-2(1:1000,Alomonelabs)and
b-actin(1:5000,Cat#A5441,Sigma).
Measurement of de novo Pprotein sSynthesis
Eight-week-oldwild-type andEif4ebp1-/- mice wereinjectedwithpuromycin (10 mg/kg,intraperito-
neal, i.p.), and 45min later DRGs were collected and processed for Western blotting, using anti-
puromycin monoclonal antibody (3RH11, KeraFast). DRGs from mice injected with anisomycin (100
mg/kgi.p,injected20 minbeforepuromycin)orvehiclewereprocessedinparallelandusedascon-
trols. Protein synthesis was determined by measuring total lane signal from 250–15 KDa and sub-
tractingunlabelledproteincontrol.SignalswerequantifiedusingImageJ.
Immunohistochemistry
Mice were deeply anaesthetized and transcardially perfused with 30 ml vascular rinse (0.1% w/v
sodium nitrite in 0.01M perfusion buffer) (for composition see Coˆte´ et al, 1993) and 200 ml fixative
solution (4% paraformaldehyde in 0.1 M PB, pH 7.4) at room temperature (RT). Spinal cords were
extracted trough laminectomy and post-fixed for 2h at 4˚C. Lumbar levels (L3-L5) of spinal cords
were sectioned using a vibratome and collected in PB saline (PBS) (50-mm thick free floating trans-
verse sections). Sections were washed in PBS containing 0.2% Triton X-100 (PBS-T; Sigma Aldrich)
for30 minatRT.Toblockunspecificstaining,sectionsweretreatedwithPBS-Tcontaining10%nor-
mal goat serum (NGS) for 1hr at RT. Sections were then incubated with primary antibodies diluted
inPBS-T containing 5% NGS, overnight at4˚C. Sections werewashed inPBS-T for 30minand incu-
batedwithsecondaryantibodiesdiluted1:800inPBS-T,atRTfor2hr,protectedfromlight.Foriso-
lectin B4 (IB4) staining, sections were incubated with IB4 conjugated to AlexaFluor 546, 1:200
(MolecularProbes)for1hratRT.Allstepswerecarriedoutunderconstantshaking.After30minof
final washes in PBS-T and 10min in PBS, sections were mounted with SlowFade Gold
(Invitrogen,Burlington,ON,Canada).Theslideswerestoredprotectedfromlightat4˚Cuntilexam-
ined by use of the Olympus confocal microscope using a 20x oil-immersion objective. Antibodies
used for immunohistochemistry were: glial fibrillary acidic protein (GFAP, 1:2000, GFAP Mouse
mAb, Cell Signalling, #3670), NEUronal Nuclei (NeuN, 1:5000, Mouse Anti-NeuN Antibody, clone
A60, MAB377), calcitonin gene-related peptide (CGRP, 1:1000, Sigma-Aldrich, C8198), substance P
(1:400,Neuromics,MO15094),HTR3A(1:200,Sigma-Aldrich,AV13046),andc-Fos(1:10000,Calbio-
chem, PC38). For detection, species-specific secondary antibodies were used: goat anti-rabbit
Alexa-Fluor 488 (1:800, Invitrogen Molecular probes) and goat anti-mouse Alexa-Fluor 546 (1:800,
InvitrogenMolecularProbes).
Lentivirus packaging and spinal cord injection
Lentiviral vectors for shRNA silencing of 4E-BP1 and a scrambled sequence were obtained from
Sigma. The Sigma MISSION shRNA vectors accession numbers were: mouse 4E-BP1
(TRCN0000075612),andtheNon-TargetshRNAControl(SHC002).EachshRNAvectorwasco-trans-
fectedintoHEK293TcellswiththelentiviruspackagingplasmidsPLP1,PLP2,andPLP-VSVG(Invitro-
gen) using Lipofectamine 2000 (Invitrogen). Viral supernatants were collected 48 and 72h post-
transfection. Supernatants were filtered through a 0.45 mm nitrocellulose filter either before being
applied to target cells in the presence of polybrene (5 mg/ml), or processed for concentration by
ultracentrifugation at 26,000 rpm/2h/4˚C with 20% sucrose cushion. Virus concentrates were resus-
pendedinserumfree media, andaliquots werestored at-80˚Cuntil use.Viral titre (TU/ml) wascal-
culatedusingpuromycinselectionofMEFsinfectedwithdifferentviralparticledilutionsandstained
with 0.2% crystal violet and 20% methanol solution. Colonies were measured using the CellCount
pluginofImageJ(NIH).Viraltitreswereadjustedto1.5107TU/mlforinvivoinjections.
For intraparenchymal spinal cord dorsal horn (SCDH) injection, mice were anaesthetized with an
i.p. injection of a cocktail containing xylazine (3.33 mg/ml), ketamine (55.55 mg/ml), and Domitor
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 14of18
Researcharticle Biochemistry Neuroscience
(0.27 mg/ml). The mouse was placed in a spinal frame and a laminectomy was used to remove spi-
nous process VL3 and VL4. Six unilateral injections of 0.25 ml (1 (cid:2) 107 viral particles/ml) were admi-
nistesred0.7 mmapart, atadepthof0.2 mm(SCDH), using aglasspipetteattached toaHamilton
syringe with plastic tubing at a rate of 0.1 ml/min. To allow for the solution containing viral particles
to diffuse from the tip of the glass pipette into the tissue, the pipette stayed in the tissue for one
additional minute. The syringe was mounted on a microinjector (Nanomite, Harvard Apparatus)
attached to a stereotaxic unit (David Kopf Instruments). The mice were allowed to recover for 1
weekbeforetheexperiments.
m7GDP pull-down
Lumbar spinal cord was homogenized in lysis buffer containing 40 mM HEPES-KOH (pH 7.5), 120
mMNaCl,1mMEDTA,0.1mMGDP,10mMpyrophosphate,10mMb-glycerophosphate,
and 50 mM NaF. Extracts were mixed with 30 ml of m7 GDP-agarose for 1.5 h at 4˚C. The resins
werewashedfourtimesandproteinswereelutedwithSDS–PAGEsamplebuffer.
Statistical Analyses
Allresultsareexpressedasmean±SEM.AllstatisticalcomparisonsweremadewitheitherStudent’s
t-testorone-wayortwo-wayANOVA,followedbybetween-groupcomparisonsusingt-testorBon-
ferroni’spost-hoctest,unlessotherwiseindicated,withp<0.05asthesignificancecriteria.
Acknowledgments
ThisworkwassupportedbyaCIHRoperatinggranttoN.Sonenberg(MOP-114994),anunrestricted
gift from the Louise and Alan Edwards Foundation to JS Mogil, a CIHR grant to Y. De
Koninck (MOP-12942) and the Louise and Alan Edwards Foundation fellowship to R. Bonin. We
thankASylvestre,SPerreault,CLister,andIHarveyfortechnicalassistance.
Additional information
Competinginterests
NS:Reviewingeditor,eLife.Theotherauthorsdeclarethatnocompetinginterestsexist.
Funding
Funder Grantreferencenumber Author
CanadianInstitutesofHealth OperatinggranttoN. ArkadyKhoutorsky
Research Sonenberg(MOP-114994) ChristosGkogkas
SeyedMehdiJafarnejad
TommyAlain
NahumSonenberg
TheLouiseandAlanEdwards AnunrestrictedgifttoJ.S. RobertESorge
Foundation Mogil LorenMartin
JeffreySMogil
Thefundershadnoroleinstudydesign,datacollectionandinterpretation,orthedecisionto
submittheworkforpublication.
Authorcontributions
AK,RPB,RES,JPS,Conceptionanddesign,Acquisitionofdata,Analysisandinterpretationofdata,
Drafting or revising the article; CGG, JSM, NS, Conception and design, Analysis and interpretation
ofdata, Draftingor revisingthearticle;SAP, SMJ,ARda-S, YDK, FC,Conceptionanddesign, Draft-
ingorrevisingthearticle;MHP,EWS,Acquisitionofdata,Analysisandinterpretationofdata,Draft-
ing or revising the article; TA, Drafting or revising the article, Contributed unpublished essential
dataorreagents;LM,Acquisitionofdata,Draftingorrevisingthearticle
AuthorORCIDs
RobertPBonin, http://orcid.org/0000-0002-3287-6803
YvesDeKoninck, http://orcid.org/0000-0002-5779-9330
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 15of18
Researcharticle Biochemistry Neuroscience
Ethics
Animalexperimentation:AllprocedurescompliedwiththeCanadianCouncilonAnimalCareguide-
lines and International Association for the Study of Pain, and were approved by McGill University’s
DowntownAnimalCareCommittee.
References
AsanteCO,WallaceVC,DickensonAH.2009.Formalin-inducedbehaviouralhypersensitivityandneuronal
hyperexcitabilityaremediatedbyrapidproteinsynthesisatthespinallevel.MolecularPain5:27doi:10.1186/
1744-8069-5-27
AsanteCO,WallaceVC,DickensonAH.2010.Mammaliantargetofrapamycinsignalinginthespinalcordis
requiredforneuronalplasticityandbehavioralhypersensitivityassociatedwithneuropathyintherat.The
JournalofPain11:1356–1367.doi:10.1016/j.jpain.2010.03.013
BankoJL.2005.Thetranslationrepressor4E-BP2iscriticalforeIF4Fcomplexformation,synapticplasticity,and
memoryinthehippocampus.JournalofNeuroscience25:9581–9590.doi:10.1523/JNEUROSCI.2423-05.2005
BankoJL,MerhavM,SternE,SonenbergN,RosenblumK,KlannE.2007.Behavioralalterationsinmicelacking
thetranslationrepressor4E-BP2.NeurobiologyofLearningandMemory87:248–256.doi:10.1016/j.nlm.2006.
08.012
BogenO,Alessandri-HaberN,ChuC,GearRW,LevineJD.2012.Generationofapainmemoryintheprimary
afferentnociceptortriggeredbyPKC activationofCPEB.JournalofNeuroscience32:2018–2026.doi:10.
1523/JNEUROSCI.5138-11.2012
BoninRP,deKoninckY.2014.Aspinalanalogofmemoryreconsolidationenablesreversalofhyperalgesia.
NatureNeuroscience17:1043–1045.doi:10.1038/nn.3758
CaoR,RobinsonB,XuH,GkogkasC,KhoutorskyA,AlainT,YanagiyaA,NevarkoT,LiuAndrewC.,AmirS,
SonenbergN.2013.Translationalcontrolofentrainmentandsynchronyofthesuprachiasmaticcircadianclock
bymTOR/4E-BP1signaling.Neuron79:712–724.doi:10.1016/j.neuron.2013.06.026
CarracedoA,MaL,Teruya-FeldsteinJ,RojoF,SalmenaL,AlimontiA,EgiaA,SasakiAT,ThomasG,KozmaSC,
PapaA,NardellaC,CantleyLC,BaselgaJ,PandolfiPP.2008.InhibitionofmTORC1leadstoMAPKpathway
activationthroughaPI3K-dependentfeedbackloopinhumancancer.JournalofClinicalInvestigation118:
3065–3074.doi:10.1172/JCI34739
ChaplanSR,BachFW,PogrelJW,ChungJM,YakshTL.1994.Quantitativeassessmentoftactileallodyniainthe
ratpaw.JournalofNeuroscienceMethods53:55–63.doi:10.1016/0165-0270(94)90144-9
Costa-MattioliM,MonteggiaLM.2013.MTORcomplexesinneurodevelopmentalandneuropsychiatric
disorders.NatureNeuroscience16:1537–1543.doi:10.1038/nn.3546
CuiJ,HeW,YiB,ZhaoH,LuK,RuanH,MaD.2014.MTORpathwayisinvolvedinADP-evokedastrocyte
activationandATPreleaseinthespinaldorsalhorninaratneuropathicpainmodel.Neuroscience275:395–
403.doi:10.1016/j.neuroscience.2014.06.030
DoliqueT,FavereauxA,Roca-LapirotO,RoquesV,Le´gerC,LandryM,NagyFre´de´ric.2013.Unexpected
associationofthe“inhibitory”neuroligin2withexcitatoryPSD95inneuropathicpain.Pain154:2529–2546.doi:
10.1016/j.pain.2013.07.035
DuanB,ChengL,BouraneS,BritzO,PadillaC,Garcia-CampmanyL,KrashesM,KnowltonW,VelasquezT,Ren
X,RossSarahE.,LowellBradfordB.,WangY,GouldingM,MaQ.2014.Identificationofspinalcircuits
transmittingandgatingmechanicalpain.Cell159:1417–1432.doi:10.1016/j.cell.2014.11.003
FerrariLF,BogenO,ChuC,LevineJD.2013.Peripheraladministrationoftranslationinhibitorsreverses
increasedhyperalgesiainamodelofchronicpainintherat.TheJournalofPain14:731–738.doi:10.1016/j.
jpain.2013.01.779
GerantonSM,Jimenez-DiazL,TorsneyC,TochikiKK,StuartSA,LeithJL,LumbBM,HuntSP.2009.A
rapamycin-sensitivesignalingpathwayisessentialforthefullexpressionofpersistentpainstates.Journalof
Neuroscience29:15017–15027.doi:10.1523/JNEUROSCI.3451-09.2009
GingrasAC,SvitkinY,BelshamGJ,PauseA,SonenbergN.1996.Activationofthetranslationalsuppressor4E-
BP1followinginfectionwithencephalomyocarditisvirusandpoliovirus.ProceedingsoftheNationalAcademy
ofSciencesoftheUnitedStatesofAmerica93:5578–5583.doi:10.1073/pnas.93.11.5578
GkogkasCG,KhoutorskyA,RanI,RampakakisE,NevarkoT,WeatherillDB,VasutaC,YeeS,TruittM,DallaireP,
MajorFranc¸ois,LaskoP,RuggeroD,NaderK,LacailleJ-C,SonenbergN.2013.Autism-relateddeficitsvia
dysregulatedeIF4E-dependenttranslationalcontrol.Nature493:371–377.doi:10.1038/nature11628
JacintoE,LoewithR,SchmidtA,LinS,Ru¨eggMA,HallA,HallMN.2004.MammalianTORcomplex2controls
theactincytoskeletonandisrapamycininsensitive.NatureCellBiology6:1122–1128.doi:10.1038/ncb1183
JiR-R,KohnoT,MooreKA,WoolfCJ.2003.CentralsensitizationandLTP:dopainandmemorysharesimilar
mechanisms?TrendsinNeurosciences26:696–705.doi:10.1016/j.tins.2003.09.017
JiangF,PangX-Y,NiuQ-S,HuaL-M,ChengM,JiY-H.2013.Activationofmammaliantargetofrapamycin
mediatesratpain-relatedresponsesinducedbyBmKi,asodiumchannel-specificmodulator.MolecularPain9:
50doi:10.1186/1744-8069-9-50
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 16of18
Researcharticle Biochemistry Neuroscience
Jime´nez-Dı´azL,Ge´rantonSM,PassmoreGM,LeithJL,FisherAS,BerliocchiL,SivasubramaniamAK,SheasbyA,
LumbBM,HuntSP,HarrisJ.2008.Localtranslationinprimaryafferentfibersregulatesnociception.PLoSONE
3:e1961doi:10.1371/journal.pone.0001961
KruegerDD,TuffyLP,PapadopoulosT,BroseN.2012.Theroleofneurexinsandneuroliginsintheformation,
maturation,andfunctionofvertebratesynapses.CurrentOpinioninNeurobiology22:412–422.doi:10.1016/j.
conb.2012.02.012
LeBacquerO,PetroulakisE,PaglialungaS,PoulinF,RichardD,CianfloneK,SonenbergN.2007.Elevated
sensitivitytodiet-inducedobesityandinsulinresistanceinmicelacking4E-BP1and4E-BP2.JournalofClinical
Investigation117:387–396.doi:10.1172/JCI29528
LiangL,TaoB,FanL,YasterM,ZhangY,TaoY-X.2013.MTORanditsdownstreampathwayareactivatedinthe
dorsalrootganglionandspinalcordafterperipheralinflammation,butnotafternerveinjury.BrainResearch
1513:17–25.doi:10.1016/j.brainres.2013.04.003
LiptonJonathanO.,SahinM.2014.TheneurologyofmTOR.Neuron84:275–291.doi:10.1016/j.neuron.2014.
09.034
MelemedjianOK,AsieduMN,TilluDV,PeeblesKA,YanJ,ErtzN,DussorGO,PriceTJ.2010.IL-6-andNGF-
inducedrapidcontrolofproteinsynthesisandnociceptiveplasticityviaconvergentsignalingtotheeIF4F
complex.JournalofNeuroscience30:15113–15123.doi:10.1523/JNEUROSCI.3947-10.2010
MelemedjianOK,AsieduMN,TilluDV,SanojaR,YanJ,LarkA,KhoutorskyA,JohnsonJ,PeeblesKA,LepowT,
SonenbergN,DussorG,PriceTJ.2011.Targetingadenosinemonophosphate-activatedproteinkinase(aMPK)
inpreclinicalmodelsrevealsapotentialmechanismforthetreatmentofneuropathicpain.MolecularPain7:70
doi:10.1186/1744-8069-7-70
MelemedjianOK,KhoutorskyA,SorgeRE,YanJ,AsieduMN,ValdezA,GhoshS,DussorG,MogilJS,
SonenbergN,PriceTJ.2013.MTORC1inhibitioninducespainviaIRS-1-dependentfeedbackactivationofERK.
Pain154:1080–1091.doi:10.1016/j.pain.2013.03.021
NorstedGregoryE,CodeluppiS,GregoryJA,SteinauerJ,SvenssonCI.2010.Mammaliantargetofrapamycin
inspinalcordneuronsmediateshypersensitivityinducedbyperipheralinflammation.Neuroscience169:1392–
1402.doi:10.1016/j.neuroscience.2010.05.067
Sotelo-SilveiraJose´ R.,HoltCE.2014.Axonalproteinsynthesisandtheregulationofprimaryafferentfunction.
DevelopmentalNeurobiology74:269–278.doi:10.1002/dneu.22133
PauseA,BelshamGJ,GingrasA-C,Donze´ O,LinT-A,LawrenceJC,SonenbergN.1994.Insulin-dependent
stimulationofproteinsynthesisbyphosphorylationofaregulatorof5’-capfunction.Nature371:762–767.doi:
10.1038/371762a0
PriceTJ,RashidMH,MillecampsM,SanojaR,EntrenaJM,CerveroF.2007.Decreasednociceptivesensitization
inmicelackingthefragilexmentalretardationprotein:roleofmGluR1/5andmTOR.JournalofNeuroscience
27:13958–13967.doi:10.1523/JNEUROSCI.4383-07.2007
PriceTJ,Ge´rantonSM.2009.Translatingnociceptorsensitivity:theroleofaxonalproteinsynthesisinnociceptor
physiology.EuropeanJournalofNeuroscience29:2253–2263.doi:10.1111/j.1460-9568.2009.06786.x
RanI,GkogkasCG,VasutaC,TartasM,KhoutorskyA,LaplanteI,ParsyanA,NevarkoT,SonenbergN,LacailleJ-
C.2013.SelectiveregulationofGluAsubunitsynthesisandAMPAreceptor-mediatedsynapticfunctionand
plasticitybythetranslationrepressor4E-BP2inhippocampalpyramidalcells.JournalofNeuroscience33:1872–
1886.doi:10.1523/JNEUROSCI.3264-12.2013
RichterJD,KlannE.2009.Makingsynapticplasticityandmemorylast:mechanismsoftranslationalregulation.
Genes&Development23:1–11.doi:10.1101/gad.1735809
SandkuhlerJ.2009.Modelsandmechanismsofhyperalgesiaandallodynia.PhysiologicalReviews89:707–758.
doi:10.1152/physrev.00025.2008
SantiniE,HuynhTN,MacaskillAF,CarterAG,PierreP,RuggeroD,KaphzanH,KlannE.2013.Exaggerated
translationcausessynapticandbehaviouralaberrationsassociatedwithautism.Nature493:411–415.doi:10.
1038/nature11782
SarbassovDD,AliSM,KimD-H,GuertinDA,LatekRR,Erdjument-BromageH,TempstP,SabatiniDM.2004.
Rictor,anovelbindingpartnerofmTOR,definesarapamycin-insensitiveandraptor-independentpathwaythat
regulatesthecytoskeleton.CurrentBiology14:1296–1302.doi:10.1016/j.cub.2004.06.054
ShihM-H,KaoS-C,WangW,YasterM,TaoY-X.2012.SpinalcordNMDAreceptor-mediatedactivationof
mammaliantargetofrapamycinisrequiredforthedevelopmentandmaintenanceofbonecancer-inducedpain
hypersensitivitiesinrats.TheJournalofPain13:338–349.doi:10.1016/j.jpain.2011.12.006
ShimobayashiM,HallMN.2014.Makingnewcontacts:themTORnetworkinmetabolismandsignalling
crosstalk.NatureReviewsMolecularCellBiology15:155–162.doi:10.1038/nrm3757
SonenbergN,HinnebuschAG.2009.Regulationoftranslationinitiationineukaryotes:mechanismsand
biologicaltargets.Cell136:731–745.doi:10.1016/j.cell.2009.01.042
TahmasebiS,AlainT,RajasekharVinagoluK.,ZhangJ-P,Prager-KhoutorskyM,KhoutorskyA,DoganY,
GkogkasChristosG.,PetroulakisE,SylvestreA,GhorbaniM,AssadianS,YamanakaY,Vinagolu-BaurJuliaR.,
TeodoroJoseG.,KimK,YangX-J,SonenbergN.2014.Multifacetedregulationofsomaticcellreprogramming
bymRNAtranslationalcontrol.CellStemCell14:606–616.doi:10.1016/j.stem.2014.02.005
WestonMC,ChenH,SwannJW.2012.Multiplerolesformammaliantargetofrapamycinsignalinginboth
glutamatergicandGABAergicsynaptictransmission.JournalofNeuroscience32:11441–11452.doi:10.1523/
JNEUROSCI.1283-12.2012
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 17of18
Researcharticle Biochemistry Neuroscience
XuJ-T,ZhaoX,YasterM,TaoY-X.2010.ExpressionanddistributionofmTOR,p70S6K,4E-BP1,andtheir
phosphorylatedcounterpartsinratdorsalrootganglionandspinalcorddorsalhorn.BrainResearch1336:46–
57.doi:10.1016/j.brainres.2010.04.010
XuQ,FitzsimmonsB,SteinauerJ,NeillAO,NewtonAC,HuaX-Y,YakshTL.2011.Spinalphosphinositide3-
kinase-akt-mammaliantargetofrapamycinsignalingcascadesininflammation-inducedhyperalgesia.Journalof
Neuroscience31:2113–2124.doi:10.1523/JNEUROSCI.2139-10.2011
XuJ-T,ZhaoJ-Y,ZhaoX,LigonsD,TiwariV,AtianjohFE,LeeC-Y,LiangL,ZangW,NjokuD,RajaSN,YasterM,
TaoY-X.2014.Opioidreceptor–triggeredspinalmTORC1activationcontributestomorphinetoleranceand
hyperalgesia.JournalofClinicalInvestigation124:592–603.doi:10.1172/JCI70236
XuJT,SunL,LutzBM,BekkerA,TaoYX.2015.Intrathecalrapamycinattenuatesmorphine-inducedanalgesic
toleranceandhyperalgesiainratswithneuropathicpain.TranslationalPerioperativeandPainMedicine2:27–
34.
ZhangW,SunX-F,BoJ-H,ZhangJ,LiuX-J,WuL-P,MaZ-L,GuX-P.2013.ActivationofmTORinthespinal
cordisrequiredforpainhypersensitivityinducedbychronicconstrictioninjuryinmice.Pharmacology
BiochemistryandBehavior111:64–70.doi:10.1016/j.pbb.2013.07.017
Khoutorskyetal.eLife2015;4:e12002.DOI:10.7554/eLife.12002 18of18